$TLYS
TILLY'S, INC. Stock $tlys

$tlys Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000162828017006055 Filed on May 31, 2017

Income Statement

Concept	2016 Q2
Revenue	$120.2M
YoY Change	0.02%
Cost Of Revenue	$87.63M
YoY Change	4.15%
Gross Profit	$32.59M
YoY Change	-9.61%
Gross Profit Margin	27.11%
Selling, General & Admin	$36.55M
YoY Change	7.76%
% of Gross Profit	112.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.810M
YoY Change	3.57%
% of Gross Profit	17.83%
Operating Expenses	$36.55M
YoY Change	7.76%
Operating Profit	-$3.967M
YoY Change	-286.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$76.00K
YoY Change	850.0%
Pretax Income	-$3.891M
YoY Change	-282.08%
Income Tax	-$1.146M
% Of Pretax Income
Net Earnings	-$2.745M
YoY Change	-314.12%
Net Earnings / Revenue	-2.28%
Basic Earnings Per Share	-$0.10
Diluted Earnings Per Share	-$0.10
COMMON SHARES
Basic Shares Outstanding	28.43M shares
Diluted Shares Outstanding	28.43M shares

Balance Sheet

Concept	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$88.40M
YoY Change	11.62%
Cash & Equivalents	$43.47M
Short-Term Investments	$44.90M
Other Short-Term Assets	$16.10M
YoY Change	33.06%
Inventory	$59.72M
Prepaid Expenses
Receivables	$5.900M
Other Receivables	$0.00
Total Short-Term Assets	$170.1M
YoY Change	7.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$98.84M
YoY Change	-2.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.031M
YoY Change	-63.15%
Total Long-Term Assets	$99.87M
YoY Change	-4.1%
TOTAL ASSETS
Total Short-Term Assets	$170.1M
Total Long-Term Assets	$99.87M
Total Assets	$270.0M
YoY Change	2.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.54M
YoY Change	-13.36%
Accrued Expenses	$18.50M
YoY Change	30.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$900.0K
YoY Change	12.5%
Total Short-Term Liabilities	$58.12M
YoY Change	3.83%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0K
YoY Change	-60.0%
Other Long-Term Liabilities	$40.00M
YoY Change	-3.15%
Total Long-Term Liabilities	$40.64M
YoY Change	-5.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.12M
Total Long-Term Liabilities	$40.64M
Total Liabilities	$98.76M
YoY Change	-0.02%
SHAREHOLDERS EQUITY
Retained Earnings	$36.87M
YoY Change	10.54%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$171.2M
YoY Change
Total Liabilities & Shareholders Equity	$270.0M
YoY Change	2.81%

Cashflow Statement

Concept	2016 Q2
OPERATING ACTIVITIES
Net Income	-$2.745M
YoY Change	-314.12%
Depreciation, Depletion And Amortization	$5.810M
YoY Change	3.57%
Cash From Operating Activities	-$7.980M
YoY Change	163.37%
INVESTING ACTIVITIES
Capital Expenditures	$4.325M
YoY Change	-14.93%
Acquisitions
YoY Change
Other Investing Activities	$5.060M
YoY Change	25200.0%
Cash From Investing Activities	$740.0K
YoY Change	-114.6%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-300.0K
YoY Change	-112.05%
NET CHANGE
Cash From Operating Activities	-7.980M
Cash From Investing Activities	740.0K
Cash From Financing Activities	-300.0K
Net Change In Cash	-7.540M
YoY Change	34.4%
FREE CASH FLOW
Cash From Operating Activities	-$7.980M
Capital Expenditures	$4.325M
Free Cash Flow	-$12.31M
YoY Change	51.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23872000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21404000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66000	USD
CY2016Q2	tlys	Numberof Storeswith Impairment NumberofStoreswithImpairment	3	store
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	43000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	138102000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	138797000	USD
CY2017Q2	tlys	Percentage Of Awards Vesting On Grant Date PercentageOfAwardsVestingOnGrantDate	0.25
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17584000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	22842000	USD
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-03
CY2017Q2	us-gaap	Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation	89000	USD
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-04-29
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001524025
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	TILLY'S, INC.
CY2017Q2	dei	Trading Symbol TradingSymbol	TLYS
CY2017Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	577000	USD
CY2017Q2	tlys	Debt Instrument Covenant Minimum Eligible Inventory DebtInstrumentCovenantMinimumEligibleInventory	50000000	USD
CY2016Q2	tlys	Impaired Long Lived Assets Heldand Used Carrying Amount ImpairedLongLivedAssetsHeldandUsedCarryingAmount	856000	USD
CY2016Q2	tlys	Impaired Long Lived Assets Heldand Used Fair Value ImpairedLongLivedAssetsHeldandUsedFairValue	174000	USD
CY2016Q2	tlys	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-851000	USD
CY2017Q2	tlys	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-1343000	USD
CY2016Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	682000	USD
CY2017Q2	tlys	Number Of States NumberOfStates	31	State
CY2016Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	8	store
CY2017Q2	tlys	Numberof Stores Testedfor Impairment NumberofStoresTestedforImpairment	7	store
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	52833000	USD
CY2017Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	54802000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	52735000	USD
CY2016Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3802000	USD
CY2017Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2094000	USD
CY2017Q1	us-gaap	Assets Assets	290506000	USD
CY2017Q2	us-gaap	Assets Assets	268363000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	195215000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	174333000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	121000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	98000	USD
CY2017Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	54923000	USD
CY2017Q2	us-gaap	Dividends Dividends	20080000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7259000	USD
CY2017Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	835000	USD
CY2017Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	612000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51020000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43474000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78994000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52813000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	0	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7546000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-26181000	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4728000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5300000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M18D
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-184000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2755000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	87631000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	88042000	USD
CY2017Q2	us-gaap	Debt Instrument Covenant Description DebtInstrumentCovenantDescription	We are required to maintain certain financial and nonfinancial covenants in accordance with the revolving credit facility. The financial covenants require certain levels of leverage and profitability, such as (i) an aggregate maximum net loss after taxes not to exceed $5 million (measured at the end of each fiscal quarter), with no more than one annual net loss after taxes for any fiscal year (in either case, excluding all charges for impairment of goodwill, other intangibles and store assets impairment on the balance sheet of WOJT, in an aggregate amount of up to $2.0 million for the relevant period), and (ii) a maximum ratio of 2.00to 1.00 for “balance sheet leverage”, defined as total liabilities divided by total tangible net worth.
CY2017Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4000	USD
CY2017Q2	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The interest charged on borrowings is either at the London Interbank Offered Rate, or LIBOR, plus 1.00%, or at the bank’s prime rate. We have the ability to select between the prime rate or LIBOR-based rate at the time of a cash advance.
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	29000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-141000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	5643000	USD
CY2017Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	5834000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	35890000	USD
CY2017Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	34356000	USD
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10203000	USD
CY2017Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9114000	USD
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5805000	USD
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5829000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5109000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5143000	USD
CY2016Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	51000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1970000	USD
CY2017Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	152000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3807000	USD
CY2016Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1308000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	32587000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	32905000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-91000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1146000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	70000	USD
CY2016Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3891000	USD
CY2016Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3509000	USD
CY2017Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2016Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3134000	USD
CY2016Q2	us-gaap	Interest Paid InterestPaid	25000	USD
CY2017Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1089000	USD
CY2016Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1536000	USD
CY2017Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2531000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8362000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7669000	USD
CY2017Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1049000	USD
CY2016Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	503000	USD
CY2017Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	748000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	268363000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Covenant Compliance LineOfCreditFacilityCovenantCompliance	we were in compliance with all of our covenants and had no outstanding borrowings under the revolving credit facility.
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	65396000	USD
CY2014Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2020-06-26
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	64534000	USD
CY2017Q2	us-gaap	Interest Paid InterestPaid	12000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	47768000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	55437000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	101286000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	98890000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	290506000	USD
CY2017Q2	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2014Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	25000000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.76
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.74
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	15.50
CY2015Q2	us-gaap	Litigation Settlement Amount LitigationSettlementAmount	2000000	USD
CY2017Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	500000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.91
CY2015Q2	us-gaap	Loss Contingency Settlement Agreement Terms LossContingencySettlementAgreementTerms	three years
CY2017Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	54923000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.69
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25750	shares
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	52833000	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	717000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-301000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-20363000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	737000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-779000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7982000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5039000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	401000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.54
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.01
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-2745000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-161000	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M1D
CY2017Q2	us-gaap	Number Of Stores NumberOfStores	222	store
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3967000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-329000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6072000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6207000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-23000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	76000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	238000	USD
CY2016Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2017Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	20080000	USD
CY2016Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	92000	USD
CY2017Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	89000	USD
CY2016Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	19943000	USD
CY2017Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	29818000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4325000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2983000	USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9541000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8513000	USD
CY2016Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	25000000	USD
CY2017Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	32022000	USD
CY2016Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
CY2017Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.76
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	4737000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89219000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	87823000	USD
CY2017Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	3989000	USD
CY2016Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	209000	USD
CY2017Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	223000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	51023000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	30604000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	120218000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	120947000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36554000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33234000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	850000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	577000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3224000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3224000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1842375	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2210925	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.98
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2210925	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.616
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.514
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.019
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1002175	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.28
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2500	shares
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2017Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4200	shares
CY2017Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	29000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	189220000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	169473000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28425000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28705000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28425000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28705000	shares
CY2017Q2	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year ends on the Saturday closest to January 31. References to the fiscal quarters ended </font><font style="font-family:inherit;font-size:10pt;">April 29, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">April 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, refer to the </font><font style="font-family:inherit;font-size:10pt;">first quarter ended</font><font style="font-family:inherit;font-size:10pt;"> as of those dates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-17-006055-index-headers.html	Edgar Link	pending
0001628280-17-006055-index.html	Edgar Link	pending
0001628280-17-006055.txt	Edgar Link	pending
0001628280-17-006055-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q1201710-q.htm	Edgar Link	pending
q12017ex311.htm	Edgar Link	pending
q12017ex312.htm	Edgar Link	pending
q12017ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlys-20170429.xml	Edgar Link	completed
tlys-20170429.xsd	Edgar Link	pending
tlys-20170429_cal.xml	Edgar Link	unprocessable
tlys-20170429_def.xml	Edgar Link	unprocessable
tlys-20170429_lab.xml	Edgar Link	unprocessable
tlys-20170429_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLYS
TILLY'S, INC. Stock $tlys

2016 Q2 Form 10-Q Financial Statement

#000162828017006055 Filed on May 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS TILLY'S, INC. Stock $tlys

2016 Q2 Form 10-Q Financial Statement

#000162828017006055 Filed on May 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLYS
TILLY'S, INC. Stock $tlys